rameters of PGCs were described in some of these reports, most of the conclusions were unreliable because of the small number of PGC cases analyzed.
Introduction
Primary gastric choriocarcinoma (PGC) is a rare tumor that is reported to account for approximately 0.08% of all gastric cancers [1] . Most PGCs have been reported to possess an adenocarcinoma component of variable extent, and pure PGC is especially rare [2] [3] [4] .
In the English-language medical literature, approximately 30 had two components. The first component was a moderately differentiated tubular adenocarcinoma, accounting for approximately 80% of the entire tumor ( Fig.  2A) . The remaining 20% of the tumor was a pleomorphic carcinoma with several syncytiotrophoblastic giant cells and hemorrhage; the histological features of this component were very suggestive of a choriocarcinoma (Fig. 2B,C) . A gradual transition between the two components was observed, and the second component consisted mainly of a protruding lesion. The single nodal metastasis was composed only of tubular adenocarcinoma cells. Positive immunohistochemical staining for the beta subunit of human chorionic gonadotropin (HCG; rabbit polyclonal antibody for HCG, diluted 1 : 200; Dako, Copenhagen, Denmark) was observed only in the choriocarcinoma-like component (Fig. 2D) . Thus, this component was diagnosed as a choriocarci- [34] noma. Based on these findings, the tumor was diagnosed as a moderately differentiated tubular adenocarcinoma with a choriocarcinoma component. In case 1, the preoperative, 2-week postoperative, and 6-month postoperative HCG levels were 1055, 44.7, and less than 0.5 mIU/ml, respectively (normal range, <0.5 mIU/ml). The patient's postoperative course was uneventful, and he remains recurrence-free 64 months after the operation.
Case 2
A 64-year-old man visited our hospital for a routine medical examination. Laboratory data showed erythema (RBC, 700 ) and a high serum alpha-fetoprotein (AFP) value (2307.2 ng/ml; normal, <9.5 ng/ml). Neither gynecomastia nor abdominal abnormalities were recognized. A chest X-ray showed no abnormal shadows.
A gastrointestinal X-ray examination revealed an ulcerated mass occupying the upper third of the stomach. The mass was endoscopically diagnosed as a gastric cancer, and a biopsy specimen taken from an elevated lesion at the tumor margin revealed a moderately differentiated tubular adenocarcinoma. A CT scan showed regional lymph node swelling and metastases in the lateral segment of the liver.
A radical total gastrectomy, with lymph node dissection, splenectomy, and partial hepatic resection was performed. At the time of the operation, a macroscopic examination showed no metastatic tumors in the retroperitoneal area.
The resected tumor was 7.0 ¥ 7.0 cm in size. The tumor had extended to the subserosa (T2), and six regional lymph node metastases were identified (N1). Grossly, the tumor showed macroscopic features consistent with a type-3 lesion. Histologically, the tumor was composed of a well-differentiated tubular adenocarcinoma and a carcinoma with pleomorphic features. The former component accounted for approximately 90% of the entire tumor. The latter component contained syncytiotrophoblastic giant cells and hemorrhage; the histological features of this component were consistent with a choriocarcinoma. The hemorrhagic component of this tumor was composed only of choriocarcinoma-like tumor cells. All six nodal metastases were composed of tubular adenocarcinoma cells. Because positive immunohistochemical staining for the beta subunit of HCG was observed only in the choriocarcinoma-like component, this component was diagnosed as a choriocarcinoma. Based on these findings, the tumor was diagnosed as a well-differentiated tubular adenocarcinoma with a choriocarcinoma component.
In case 2, the preoperative and 2-week postoperative HCG levels were 246.9 and 2.3 mIU/ml, respectively. The patient's immediate postoperative course was uneventful, and he was treated with combination chemotherapy consisting of cisplatin (CDDP) and carboplatin (CPT-11) [5, 6] , as for AFP-producing gastric cancer. However, multiple liver metastases were detected 1 month after the operation, and his serum AFP level increased to 2307.2 ng/ml. The patient died 6 months after the operation.
Reported PGC cases and pooled analysis

Cases and methods
We retrospectively collected all the reported PGC cases and chose all operated cases (curative or noncurative) with a clear postoperative prognosis. Fifty-three cases of PGC have been documented previously [1-4,7-33] including the 2 cases reported here. All cases were classified according to the pTNM classification [34] . Measurement of the overall survival (OS) periods began at the time of surgery. Death due to gastric cancer was the only endpoint considered for the purpose of this study. The OS curves were drawn using the Kaplan-Meier method, and differences between the curves were compared using log-rank tests. The Cox proportional hazards regression model was used to estimate the multivariate hazard risk (HR) of tumor death (with a 95% confidence interval [CI] ). The following variables were examined as potential prognostic factors: (1) sex, (2) age (<64 years or м64 years), (3) depth of invasion (T2 or T3, T4), (4) size (<7 cm or м7 cm), (5) histology ([adenocarcinoma > choriocarcinoma] or [choriocarcinoma > adenocarcinoma]), (6) regional lymph node metastasis (negative or positive), (7) distant lymph node metastasis (negative or positive), (8) synchronous liver metastasis (absent or present), (9) residual tumor after operation (absent or present), and (10) chemotherapy (not given or given). The cutoff values for size and age in this study were the median values for the patients in the pooled analysis. The variables associated with a significant increase in the HR of tumor death in the univariate analysis were entered into the multiple regression analysis, using the step-down method.
Results of pooled analysis
Clinicopathological and follow-up data from the patients are presented in Table 1 . Thirty-seven men and 16 women were included in the analysis (M/F ratio, 2.3 : 1). The mean age of the men was 62.4 years (median, 63 years; range, 32-83 years) and that of the women was 54.8 years (median, 63 years; range, 26-74 years). In the 51 previously reported patients, the PGC was most frequently located in the lower third of the stomach (41%; 21/51), followed by the middle third (37%; 19/51) and the upper third (22%; 11/51); the location frequently coincided with the location of the gastric adenocarcinoma [4] . The tumor sizes ranged from 2 to 18 cm (mean, 7.0 cm) in diameter, and nearly all the tumors were accompanied by macroscopic hemorrhage or necrosis. Thirty-seven patients (70%) had PGCs that exhibited an adenocarcinoma component. Most patients with PGC had metastatic lesions at the time of operation. The rates of lymph node, liver, peritoneal, and lung metastases were 87% (40/46), 45% (24/53), 23% (12/53), and 8% (4/53), respectively. Denominators indicate numbers of patients for whom the parameter was mentioned. The percentages of patients with a choriocarcinoma component in the lymph node and liver were 63% (19/30) and 96% (24/25), respectively. All patients with PGC had invasion beyond the muscularis propria (T2-T4). Postoperatively, residual tumor was found in 31 of the 53 patients (58%), because of distant metastasis. The most frequent cause of death was hepatic failure because of tumor metastasis (29%; 12/41), followed by the bleeding of primary or metastatic tumors (24%; 10/ 41). Only 8% (4/53) of the PGC cases were diagnosed correctly by endoscopic biopsy.
On univariate and multivariate analyses, the presence of synchronous liver metastasis, the presence of residual tumor after operation, and the absence of chemotherapy were significantly associated with a short OS ( Table 2) . On the univariate analysis, the other parameters showed no significant association with a short OS. The OS curves are shown in Fig. 3A-C . Of the 53 patients, 10 died less than 1 month postoperatively (19%; Table 1 ).
Discussion
Davidsohn [35] first described PGC in 1905, and approximately 140 cases have been reported in the international medical literature to date. However, most of Several studies have indicated that the pathogenesis of PGC can be explained as the dedifferentiation of malignant adenocarcinoma tissue to the level of the embryonal ectoderm, retaining the ability to form trophoblasts [20, 36] . Liu et al. [37] reported, with a comparative genomic hybridization and fluorescence in situ hybridization study, that PGC genetically possessed characteristics of both adenocarcinoma and gestational choriocarcinoma. In fact, the clinical features of gastric choriocarcinoma are similar to those of gastric adenocarcinoma; the mean age, male-female ratio, and tumor location all parallel those of primary gastric adenocarcinoma [27] . In the present two patients, the PGCs were accompanied by adenocarcinoma and exhibited a gradual transition from adenocarcinoma to choriocarcinoma components. These observations strongly suggest that the PGCs in the present patients originated from pre-existing gastric adenocarcinomas.
PGC is often diagnosed as adenocarcinoma because of the coexistence of adenocarcinoma and choriocarcinoma. That is why our patients were preoperatively diagnosed as having adenocarcinoma from endoscopic biopsy specimens. Only 8% (4/53) of the PGC cases were diagnosed correctly by biopsy.
Using univariate and multivariate analyses, our results demonstrated that synchronous liver metastasis, residual tumor after surgery, and the absence of chemotherapy were significant prognostic parameters of a short OS. One of the main characteristics of the PGC patients was early death after operation because of hepatic failure, brought on by tumor metastasis, and bleeding of the primary or metastatic tumors. Of the ten patients who died within 1 month after operation, nine (90%) had synchronous liver metastasis. In the present report, case 2 died of liver metastasis in spite of receiving a curative operation and chemotherapy. The presence of synchronous liver metastasis at the time of operation may represent an advanced metastatic state and may be associated with a poor clinical course in PGC patients. We suggest that a palliative gastrectomy should never be performed in such patients, as it is likely that the patients would die soon after such a procedure. Regional and distant lymph node metastases, which are potent prognostic factors for many tumors, were not significant prognostic parameters in the present study. Therefore, PGCs with a high metastatic potential, especially to the liver, may have the highest malignant potential among PGCs with tumor metastasis. Our case 1 has survived for 5 years and 4 months since receiving a curative operation. There is no established regimen of chemotherapy for PGC. Based on these clinicopathological findings, we speculated that a combination of R0 resection and adequate chemotherapy may contribute to the long-term survival of PGC patients.
The present study suggests that PGC is a highly aggressive tumor that is often associated with liver metastasis. Curative resection, appropriate chemotherapy, and the absence of synchronous liver metastasis are favorable prognostic factors for patients with PGC. 
